Skip to main content

Together we are beating cancer

Donate now

Breast cancer

Breast cancer is the most common cancer in the UK, with around 55,200 people diagnosed each year. It starts in the breast tissue, most commonly in cells lining the milk ducts. Breast cancer predominantly affects women, but men can get it too.
Showing 12 out of 632 results
Cancer Research UK logo

A drug commonly used to prevent and treat bones losing density and becoming brittle known as osteoporosis may also help reduce the risk of breast cancer by one third or more according to new research published in the British Journal of Cancer today. A drug commonly used to prevent and treat bones losing density and becoming brittle known as osteoporosis may also help reduce the risk of breast cancer by one third or more according to new research published in the British Journal of Cancer today.

by British Journal of Cancer | News | 3 March 2010

3 March 2010

Cancer Research UK logo

Cancer Research UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology today. Cancer Research UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology today.

by Cancer Research UK | News | 1 March 2010

1 March 2010

Cancer Research UK logo
  • Health & Medicine
  • Science & Technology

Scientists unlock key to tamoxifen resistance

Cancer Research UK funded scientists have discovered why some breast cancers are resistant to the commonly used drug tamoxifen, their findings are published in Cancer Research. Cancer Research UK funded scientists have discovered why some breast cancers are resistant to the commonly used drug tamoxifen, their findings are published in Cancer Research.

by Cancer Research UK | News | 23 February 2010

23 February 2010

Cancer Research UK logo

The chronic side-effects of radiotherapy for early breast cancer, as reported by women themselves, are not any worse when treatment is given in a lower overall dose in fewer but larger treatments according to a trial part funded by Cancer Research UK and published today in the Lancet Oncology. The chronic side-effects of radiotherapy for early breast cancer, as reported by women themselves, are not any worse when treatment is given in a lower overall dose in fewer but larger treatments according to a trial part funded by Cancer Research UK and published today in the Lancet Oncology.

by Cancer Research UK | News | 8 February 2010

8 February 2010

Cancer Research UK logo

Dundee today (Thursday) becomes Scotland's first link in a unique chain of Cancer Research UK Centres that are being launched across the UK. The launch of the Dundee Centre coincides with World Cancer Day. Dundee today (Thursday) becomes Scotland's first link in a unique chain of Cancer Research UK Centres that are being launched across the UK. The launch of the Dundee Centre coincides with World Cancer Day.

by Cancer Research UK | News | 4 February 2010

4 February 2010

Cancer Research UK logo

Over 60 per cent of women who have a form of breast cancer in the milk ducts (DCIS*) are spared a mastectomy, according to latest research published today in the British Journal of Cancer. Over 60 per cent of women who have a form of breast cancer in the milk ducts (DCIS*) are spared a mastectomy, according to latest research published today in the British Journal of Cancer.

by British Journal of Cancer | News | 19 January 2010

19 January 2010

Cancer Research UK logo

Cancer Research UK scientists have shown for the first time how preventing two receptors - 'cell antennae' - communicating with each other can influence the activity of oestrogen, the hormone that fuels the progression of breast cancer in many women. The research is published in Genes and Development today (Thursday). Cancer Research UK scientists have shown for the first time how preventing two receptors - 'cell antennae' - communicating with each other can influence the activity of oestrogen, the hormone that fuels the progression of breast cancer in many women. The research is published in Genes and Development today (Thursday).

by Cancer Research UK | News | 14 January 2010

14 January 2010

Cancer Research UK logo

Cancer Research UK funded scientists have found that a group of rogue genetic messengers, produced by DNA sequences commonly known as `junk DNAї, could help diagnose breast and bowel cancer. Their research is published in the journal Genomics. Cancer Research UK funded scientists have found that a group of rogue genetic messengers, produced by DNA sequences commonly known as `junk DNAї, could help diagnose breast and bowel cancer. Their research is published in the journal Genomics.

by Cancer Research UK | News | 5 January 2010

5 January 2010